Skip to main content

ORIGINAL RESEARCH article

Front. Aging Neurosci. , 11 August 2022

Sec. Alzheimer's Disease and Related Dementias

Volume 14 - 2022 | https://doi.org/10.3389/fnagi.2022.960246

This article is part of the Research Topic The Alzheimer's Disease Challenge, Volume II View all 14 articles

RETRACTED: QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics

Retracted
\nDeepshi Arora,Deepshi Arora1,2Shailendra BhattShailendra Bhatt3Manish Kumar Manish Kumar1*Ravinder VermaRavinder Verma3Yugam TanejaYugam Taneja4Nikita KaushalNikita Kaushal1Abhishek TiwariAbhishek Tiwari5Varsha TiwariVarsha Tiwari5Athanasios Alexiou,Athanasios Alexiou6,7Sarah AlbogamiSarah Albogami8Saqer S. AlotaibiSaqer S. Alotaibi8Vineet MittalVineet Mittal9Rajeev K. Singla,Rajeev K. Singla10,11Deepak Kaushik Deepak Kaushik9*Gaber El-Saber Batiha Gaber El-Saber Batiha12*
  • 1M.M. College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Ambala, Haryana, India
  • 2Guru Gobind Singh College of Pharmacy, Yamuna Nagar, Haryana, India
  • 3Department of Pharmacy, G.D. Goenka University, Gurugram, Haryana, India
  • 4Zeon Lifesciences Pvt. Ltd., Paonta Sahib, Himachal Pradesh, India
  • 5Pharmacy Academy, IFTM University, Moradabad, UP, India
  • 6Department of Science and Engineering, Novel Global Community Educational Foundation, Hebersham, NSW, Australia
  • 7AFNP Med Austria, Wien, Austria
  • 8College of Science, Taif University, Taif, Saudi Arabia
  • 9Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India
  • 10Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China
  • 11iGlobal Research and Publishing Foundation, New Delhi, India
  • 12Faculty of Veterinary Medicine, Department of Pharmacology and Therapeutics, Damanhour University, Damanhour, Egypt

A retraction of this article was approved in:

  1. Retraction: QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics

    1. Read retraction

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Arora D, Bhatt S, Kumar M, Verma R, Taneja Y, Kaushal N, Tiwari A, Tiwari V, Alexiou A, Albogami S, Alotaibi SS, Mittal V, Singla RK, Kaushik D and Batiha G-S (2022) QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics. Front. Aging Neurosci. 14:960246. doi: 10.3389/fnagi.2022.960246

Received: 02 June 2022; Accepted: 14 July 2022;
Published: 11 August 2022; Retracted: 28 March 2024.

Edited by:

Patrick R. Hof, Icahn School of Medicine at Mount Sinai, United States

Reviewed by:

Ashok Iyaswamy, Hong Kong Baptist University, Hong Kong SAR, China
Simona Cavalu, University of Oradea, Romania

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

Man ultramarathon runner in the mountains he trains at sunset

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more